Bae Edward, White Paul, Brophy Mary, Lichtman Michael, Krathen Michael S, Mahalingam Meera
*Department of Dermatology, Boston University School of Medicine, Boston, MA;†Department of Hematology and Oncology, Boston Medical Center, Boston, MA;‡Massachusetts Area Veterans Epidemiology Research and Information Center (MAVERIC), VA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA;§Department of Internal Medicine, Boston University School of Medicine, Boston, MA;¶Dermatology Section, Department of Internal Medicine, VA Medical Center, Boston, MA; and‖Dermatopathology Section, Department of Pathology and Laboratory Medicine, VA Medical Center, Boston, MA.
Am J Dermatopathol. 2017 Oct;39(10):776-781. doi: 10.1097/DAD.0000000000000875.
Cutaneous Rosai-Dorfman disease (CRDD), a benign histiocytosis of unknown etiology, typically presents as a solitary or clusters of lesions. Although the histopathology is fairly distinctive, the laboratory abnormalities are not; past reports note elevated erythrocyte sedimentation rate, anemia, and polyclonal hyperglobulinemia. We describe a 61-year-old African American diabetic gentleman who presented with nodules in a linear distribution on the flank. Histopathologic examination of a biopsied nodule revealed a pandermal sheet-like infiltrate of plasma cells and histiocytes, some demonstrating elastophagocytosis and emperipolesis. The lesional histiocytes were S100 and CD68 positive and CD1a negative-findings consistent with a diagnosis of CRDD. Additional laboratory work-up performed 12 weeks after the biopsy was taken revealed an elevated serum κ light chain concentration of 37.26 mg/L (reference range: 3.30-19.40 mg/L), which correlated with an M-protein spike identified as IgG κ proteins per serum protein electrophoresis. Given the difficulty in excising a large area and preexisting diabetes, a course of low-dose methotrexate was selected for therapy with a recommendation of close follow-up for the monoclonal gammopathy. To the best of our knowledge, this is the first report of CRDD associated with a linear distribution of lesions and serum protein electrophoresis-confirmed monoclonal gammopathy.
皮肤型罗萨伊-多夫曼病(CRDD)是一种病因不明的良性组织细胞增多症,通常表现为单个或成簇的病变。尽管组织病理学特征相当独特,但实验室异常表现并不特异;既往报道指出红细胞沉降率升高、贫血和多克隆高球蛋白血症。我们描述了一位61岁的非裔美国糖尿病男性患者,其侧腹出现呈线性分布的结节。对一个活检结节进行组织病理学检查发现,真皮全层有浆细胞和组织细胞呈片状浸润,部分细胞显示有噬弹力纤维现象和血细胞吞噬现象。病变组织细胞S100和CD68呈阳性,CD1a呈阴性,这些结果符合CRDD的诊断。活检后12周进行的进一步实验室检查显示,血清κ轻链浓度升高至37.26 mg/L(参考范围:3.30 - 19.40 mg/L),这与血清蛋白电泳鉴定为IgG κ蛋白的M蛋白峰相关。鉴于大面积切除困难且患者存在糖尿病,选择了低剂量甲氨蝶呤进行治疗,并建议对单克隆丙种球蛋白病进行密切随访。据我们所知,这是首例关于CRDD伴病变呈线性分布且经血清蛋白电泳证实为单克隆丙种球蛋白病的报道。